Ad-hoc | 21 March 2017 14:57
aap Implantate AG: Sales by KEUR 514 and EBITDA by KEUR 450 slightly below guidance for financial year 2016 due to failure of distributor to fulfil contractual duties
|
aap Implantate AG / Key word(s): Profit Warning/Final Results
aap Implantate AG (“ aap “) announces that in course of drawing up the annual financial statements for 2016 the Management Board decided as a precautionary measure to revoke an initial sale with a distribution partner invoiced in the financial year. The reason is a delayed payment of the contractual due purchase price. Rescission of the initial business results in a reduction in sales in the financial year 2016 by KEUR 757. In the continued operation in financial year 2016 sales are at EUR 10.5 million and EBITDA at EUR -7.9 million and thereby slightly below the current guidance. Contact: aap Implantate AG; Fabian Franke; Investor Relations; Lorenzweg 5; D-12099 Berlin Tel.: ++49/30/750 19 – 134; Fax.: ++49/30/750 19 – 290; f.franke@aap.de
21-March-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
| Language: | English |
| Company: | aap Implantate AG |
| Lorenzweg 5 | |
| 12099 Berlin | |
| Germany | |
| Phone: | +49 (0) 30 75 01 90 |
| Fax: | +49 (0) 30 75 01 91 11 |
| E-mail: | info@aap.de |
| Internet: | www.aap.de |
| ISIN: | DE0005066609 |
| WKN: | 506660 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |